Insilico announces a multi-target AI-powered drug discovery co...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
BEIJING, Nov. 10, 2020 /PRNewswire-AsiaNet/ -- Insilico Medicine, a leader in deep generative reinforcement learning for target discovery, small molecule generation, and prediction of clinical trial outcomes, today announced that it entered into a multi-target drug discovery agreement with Jan...
Authors: LATEST ASIANET NEWS RELEASES